Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Traws Pharma Q2 2025 GAAP EPS $(0.11) Up From $(20.52) YoY, Sales $2.733M Up From $57.000K YoY

Author: Benzinga Newsdesk | August 14, 2025 06:04am
Traws Pharma (NASDAQ:TRAW) reported quarterly losses of $(0.11) per share. This is a 99.46 percent increase over losses of $(20.52) per share from the same period last year. The company reported $2.733 million in sales this quarter. This is a 4.69K percent increase over sales of $57.000 thousand the same period last year.

Posted In: TRAW


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist